Cost-Effectiveness Analysis of Eltrombopag as Support Treatment in Chronic HCV Infected Patients With Thrombocytopenia to Enable Interferon-Based Regimens
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1692
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV